- Home
- PNNT vs HQL Comparison
PNNT vs HQL Comparison
Compare PNNT & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNNT
- HQL
- Stock Information
- Founded
- PNNT 2007
- HQL 1992
- Country
- PNNT United States
- HQL United States
- Employees
- PNNT N/A
- HQL N/A
- Industry
- PNNT Finance: Consumer Services
- HQL Investment Managers
- Sector
- PNNT Finance
- HQL Finance
- Exchange
- PNNT Nasdaq
- HQL Nasdaq
- Market Cap
- PNNT 442.7M
- HQL 369.6M
- IPO Year
- PNNT 2007
- HQL N/A
- Fundamental
- Price
- PNNT $6.70
- HQL $12.76
- Analyst Decision
- PNNT Sell
- HQL
- Analyst Count
- PNNT 3
- HQL 0
- Target Price
- PNNT $5.88
- HQL N/A
- AVG Volume (30 Days)
- PNNT 343.8K
- HQL 120.9K
- Earning Date
- PNNT 08-06-2025
- HQL 01-01-0001
- Dividend Yield
- PNNT 14.33%
- HQL 11.56%
- EPS Growth
- PNNT N/A
- HQL N/A
- EPS
- PNNT 0.73
- HQL 0.79
- Revenue
- PNNT $138,371,000.00
- HQL N/A
- Revenue This Year
- PNNT N/A
- HQL N/A
- Revenue Next Year
- PNNT N/A
- HQL N/A
- P/E Ratio
- PNNT $9.18
- HQL $17.08
- Revenue Growth
- PNNT N/A
- HQL N/A
- 52 Week Low
- PNNT $5.72
- HQL $11.34
- 52 Week High
- PNNT $8.04
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- PNNT 49.14
- HQL 54.43
- Support Level
- PNNT $6.59
- HQL $12.34
- Resistance Level
- PNNT $6.78
- HQL $12.74
- Average True Range (ATR)
- PNNT 0.12
- HQL 0.21
- MACD
- PNNT -0.02
- HQL -0.02
- Stochastic Oscillator
- PNNT 29.00
- HQL 53.85
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.